| Net Cash Provided by (Used in) Operating Activities |
$324,729 |
USD |
-100% |
Q2 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q2 2024 |
Q1 2025 |
| Common Stock, Shares, Issued |
172,202,165 |
shares |
20% |
Q2 2024 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$47,391 |
USD |
400% |
Q2 2024 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q2 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,238,858 |
USD |
-30% |
Q1 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,238,858 |
USD |
-30% |
Q1 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q2 2024 |
Q1 2025 |
| Additional Paid in Capital |
$23,951,105 |
USD |
15% |
Q2 2024 |
Q1 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q1 2024 |
FY 2024 |
| Interest Expense |
$149,472 |
USD |
-91% |
Q2 2024 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |